LEXARIA BIOSCIENCE CORP. Accumulated Other Comprehensive Income
LEXARIA BIOSCIENCE CORP. (LEXX) had Accumulated Other Comprehensive Income of -$46.47 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-13
- 2026-05-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$46.47K.
- 2026-02-28: Accumulated Other Comprehensive Income (Loss), Net of Tax -$55.44K.
- 2025-11-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$76.08K.
- 2025-08-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$70.33K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-05-31 | -$46.47K 10-Q · filed 2026-07-13 |
| 2026-02-28 | -$55.44K 10-Q · filed 2026-04-13 |
| 2025-11-30 | -$76.08K 10-Q · filed 2026-01-13 |
| 2025-08-31 | -$70.33K 10-Q · filed 2026-07-13 |
| 2025-05-31 | -$81.07K 10-Q · filed 2025-07-14 |
| 2025-02-28 | -$118.25K 10-Q · filed 2025-04-14 |
| 2024-11-30 | -$22.99K 10-Q · filed 2025-01-10 |
| 2024-08-31 | -$19.82K 10-K · filed 2025-11-28 |
| 2024-05-31 | -$21.87K 10-Q · filed 2024-07-12 |
| 2024-02-29 | -$20.63K 10-Q · filed 2024-04-09 |
| 2023-11-30 | $4.37K 10-Q · filed 2024-01-12 |
| 2023-08-31 | $0.00 10-K · filed 2024-11-26 |
| 2018-08-31 | -$14.25K 10-K · filed 2019-11-14 |
| 2018-05-31 | -$7.38K 10-Q · filed 2018-07-13 |
| 2017-08-31 | $0.00 10-Q · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |